Home > Insider Trading > Glaxosmithkline Plc

Glaxosmithkline Plc (GSK)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
141 - 150
Next >>

GlaxoSmithKline PLC (ADR) (GSK) Poised To Overtake Sanofi SA (ADR) (SNY) In This $1.8 Billion Market

GlaxoSmithKline PLC (ADR) (NYSE:GSK) is on the verge of leapfrogging Sanofi SA (ADR) (NYSE:SNY) in the meningococcal vaccine market in terms of sales.

Keep Reading →

June 8th, 2016 - News Stock Analysis

A Look at Top Picks of This Billion-Dollar Healthcare-Focused Fund

Deerfield Management, a healthcare-focused fund managed by James E.

Keep Reading →

December 11th, 2015 - Hedge Funds News

Is GlaxoSmithKline plc (ADR) (GSK) A Good Stock To Buy?

Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren't very good.

Keep Reading →

November 27th, 2015 - Hedge Funds News

11 Biggest Generic Drug Companies in the World

When it comes to 11 Biggest Generic Drug Companies in the World one can say that the list hasn’t changed a great deal over the years.

Keep Reading →

June 27th, 2015 - Lists

Valeant Pharmaceuticals Intl Inc (VRX), Apple Inc. (AAPL), McDonald's Corporation (MCD): A Look At Locust Wood's Major First Quarter Moves

Hedge funds have started submitting their 13F filings with the SEC, offering other investors a chance to look at their equity holdings as of the end of the first quarter. One such fund is Stephen J.

Keep Reading →

April 24th, 2015 - Hedge Funds News

GlaxoSmithKline plc (ADR) (GSK) Nearing on Ebola Eradication

GlaxoSmithKline plc (ADR) (NYSE:GSK) remains committed to eradicating the deadly virus which has already claimed more than 2,000 lives in Western Africa and is considered as the worst occurrence of such...

Keep Reading →

September 8th, 2014 - News

Chinese Trial May Not Be Linked to GlaxoSmithKline plc (ADR) (GSK)

Companies around the world, who do business in China were keeping a close watch on the trial of the British company investigator, Peter Humphrey, and his American wife and business partner, Yu Yingzeng...

Keep Reading →

August 10th, 2014 - News